Plans to reduce its workforce by 55% to extend its cash runway as the company explores strategic alternatives with the goal of maximizing stockholder value.
ZeClinics will leverage Almirall's state-of-the-art technology facilities to accelerate drug discovery by providing high-throughput safety and efficacy screenings.
Yinjia Biosciences will provide Porton Advanced with high-quality core protein raw materials and testing reagent products for quality control and evaluation systems.
CBM will manufacture and partner with Virion on their checkpoint modifier clinical development programs, including the First-in-Human VRON-0200 immunotherapy.
As a company producing Oral Solid Dose drug products, how can Pharmaceutical Continuous Manufacturing solve specific problems and help your business thrive?
The lab will contain 48 workbenches with services that include mass spectrometry and ligand binding assays, flow cytometry, biomarkers, and cell culture.